Antithetical modes of and the Ca2+ sensors targeting in ANF-RGC and ROS-GC1 membrane guanylate cyclases by Duda, Teresa et al.
ORIGINAL RESEARCH ARTICLE
published: 06 April 2012
doi: 10.3389/fnmol.2012.00044
Antithetical modes of and the Ca sensors targeting in
ANF-RGC and ROS-GC1 membrane guanylate cyclases
2+
Teresa Duda
1*, Alexandre Pertzev
1, Karl-W. Koch
2 and Rameshwar K. Sharma
1
1 Research Divisions of Biochemistry and Molecular Biology, The Unit of Regulatory and Molecular Biology, Salus University, Elkins Park, PA, USA
2 Department of Biology and Environmental Sciences, Biochemistry Group, University of Oldenburg, Oldenburg, Germany
Edited by:
Michael R. Kreutz, Leibniz-Institute
for Neurobiology, Germany
Reviewed by:
Frank Schmitz, Saarland University,
Germany
Lee Haynes, The University of
Liverpool, UK
*Correspondence:
Teresa Duda, Research Divisions of
Biochemistry and Molecular Biology,
The Unit of Regulatory and
Molecular Biology, Salus University,
8360 Old York Road, Elkins Park,
PA 19027 , USA.
e-mail: tduda@salus.edu
The membrane guanylate cyclase family has been branched into three subfamilies:
natriuretic peptide hormone surface receptors, Ca2+-modulated neuronal ROS-GC, and
Ca2+-modulated odorant surface receptor ONE-GC. The ﬁrst subfamily is solely modulated
by the extracellularly generated hormonal signals; the second, by the intracellularly
generated sensory and sensory-linked signals; and the third, by combination of these
two. The present study deﬁnes a new paradigm and a new mechanism of Ca2+ signaling.
(1) It demonstrates for the ﬁrst time that ANF-RGC, the prototype member of the surface
receptor subfamily, is stimulated by free [Ca2+]i. The stimulation occurs via myristoylated
form of neurocalcin δ, and both the guanylate cyclase and the calcium sensor neurocalcin δ
are present in the glomerulosa region of the adrenal gland. (2) The EF-2, EF-3 and
EF-4 hands of GCAP1 sense the progressive increment of [Ca2+]i a n dw i t haK 1/2 of
100nM turn ROS-GC1 “OFF .” In total reversal, the same EF hands upon sensing the
progressive increment of [Ca2+]i with K1/2 turn ONE-GC “ON.” The ﬁndings suggest a
universal Ca2+-modulated signal transduction theme of the membrane guanylate cyclase
family; demonstrate that signaling of ANF-RGC occurs by the peptide hormones and
also by [Ca2+]i signals; that for the Ca2+ signal transduction, ANF-RGC functions as a
two-component transduction system consisting of the Ca2+ sensor neurocalcin δ and
the transducer ANF-RGC; and that the neurocalcin δ in this case expands beyond its
NCS family. Furthermore, the study shows a novel mechanism of the [Ca2+]i sensor
GCAP1 where it acts as an antithetical NCS for the signaling mechanisms of ROS-GC1
and ONE-GC.
Keywords: calcium, GCAP1, neurocalcin δ, neuronal calcium sensors, membrane guanylate cyclase, cyclic GMP ,
atrial natriuretic factor receptor membrane guanylate cyclase, olfactory neuroepithelium membrane guanylate
cyclase
INTRODUCTION
Ca2+ sensor proteins form a group of Ca2+ binding proteins
that,indeﬁnedconcentrations offreeintracellularCa2+,function
as modulators of the activities of speciﬁc target proteins. They
acquire these modulatory abilities by binding Ca2+ through spe-
ciﬁc helix-loop-helix structural motifs called EF hands. Binding
of Ca2+ to the EF hand motif triggers conformational changes
in the respective Ca2+ sensor protein that enable it to per-
form Ca2+-dependent functions ranging from regulation of ion
channels permeability to gene expression, cellular survival and
apoptosis (reviewed in Bhattacharya et al., 2004; Braunewell,
2005). Neuronal Ca2+ sensor (NCS) proteins constitute a sub-
family of Ca2+ sensor proteins and were initially considered to
be expressed exclusively in neurons, but now are found in other
tissues as well. NCS proteins are subclassiﬁed into ﬁve groups
based on their sequence similarities. In mammals, 14 conserved
NCS proteins exist (reviewed in Burgoyne, 2007)a n da l lo ft h e m
have 4 EF hand Ca2+ binding motifs but inactivating amino
acid substitutions make the ﬁrst EF hand non-functional for
Ca2+ binding. In addition to the ﬁrst inactive EF hand, recov-
erin and K+-channel interacting protein type1 (KChIP1) harbor
another non-functional EF hand. Except for KChIP2, 3 and 4 all
mammalian NCS proteins contain a consensus sequence for N-
terminal myristoylation (reviewed in Burgoyne and Weiss, 2001;
Burgoyne et al., 2004). Some isoforms of KChIP2 and 3 are
possibly palmitoylated (Takimoto et al., 2002). Both myristoy-
lation and palmitoylation of NCS proteins allows for some of
them membrane association, either permanently or transiently in
response to changes in the intracellular Ca2+ concentration. For
GCAP1 and NCS-1, however, Ca2+ plays no role in membrane
attachment of the protein (Hwang and Koch, 2002; O’Callaghan
et al., 2002; Orban et al., 2010).
Neurocalcin δ together with visinin-like proteins (VILIPs) and
hippocalcin form a distinct subfamily of NCS proteins. It is acy-
lated at the N-terminus by myristic acid and undergoes a classical
calcium-myristoyl switch (Ladant, 1995)e . g .i tb u r i e st h em y r i s -
toyl group in a hydrophobic pocket in a Ca2+-free form and
expose it in Ca2+-bound form as it is observed for recoverin
(Zozulya and Stryer, 1992). However, once it binds in a Ca2+-
dependent fashion to the membrane phospholipids part of it
remains membrane bound even after removing Ca2+ by the addi-
tion of EGTA (Krishnan et al., 2004). Although the highest level
of neurocalcin δ has been detected in neuronal tissues, its expres-
sion level in peripheral tissues is also signiﬁcant. Functionally,
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neurocalcin δ has been linked to receptor endocytosis through
interaction with α-a n dβ-clathrin and β-adaptin (Ivings et al.,
2002), trafﬁcking and membrane delivery of glutamate receptors
of the kainate type (Coussen and Mulle, 2006), and due to its
Ca2+-dependent afﬁnity for S100B protein and tubulin β-chain
(Okazaki et al., 1995), with microtubule assembly (Iino et al.,
1995). In the sensory and sensory-linked neurons, the presence
of neurocalcin δ has been found in the inner plexiform layer
of the retina, e.g. in the amacrine and ganglion cells (Krishnan
et al., 2004), olfactory sensory neurons (Duda et al., 2001, 2004)
and very recently, it has been identiﬁed in type II cells of mouse
circumvallate taste papillae, indicating its possible role in the
gustatory transduction (Rebello et al., 2011).
Further, neurocalcin δ can act as Ca2+-dependent modulator
of membraneguanylate cyclaseROS-GC1 in the retina and ONE-
GC, in the olfactory neuroepithelium. There, it co-localizes with
its respective target guanylate cyclases (Duda et al., 2001, 2004;
Krishnan et al., 2004). The exact physiological signiﬁcance of the
ROS-GC1-neurocalcin δ signaling system in the retinal neurons
is not known yet, it has, however, been proposed that the sys-
tem may beinvolved in synaptic processes (Krishnan et al., 2004).
In the olfactory neuroepithelium neurocalcin δ serves as a Ca2+
sensor component of the two-step odoranturoguanylin signaling
machinery (Duda and Sharma, 2009).
Guanylate cyclase activating protein type 1 (GCAP1) is a well
characterized member of the NCS proteins subfamily (reviewed
in Palczewski et al., 2004; Sharma et al., 2004; Behnen et al.,
2010; Koch et al., 2010). Like other homologs and orthologs of
the subfamily, it harbors four EF hand Ca2+ binding motifs,
of which the ﬁrst one is inactive. GCAP1 is acylated at the N-
terminus by myristic acid that is buried in a hydrophobic pocket
(Stephen et al., 2007) and changing Ca2+ concentrations do not
trigger exposure of the myristoyl group (Orban et al., 2010).
Instead the myristoyl group remains buried in a hydrophobic
cavity. Thus, GCAP1 does not interact with the membranes in
aC a 2+-dependent fashion (Hwang and Koch, 2002; Haynes and
Burgoyne, 2008) and does not undergo a classical calcium myris-
toylswitch. Identiﬁedﬁrstintheretinal photoreceptors(Gorczyca
et al., 1994; Frins et al., 1996), GCAP1 transmits Ca2+ signals to
and controls the activity of rod outer segment guanylate cyclase,
ROS-GC. It activates ROS-GC in the absence of Ca2+,w h e n
immediately after illumination the cytoplasmic Ca2+ drops in
a photoreceptor cell. GCAPs are thought to switch to a Ca2+-
free but Mg2+-bound state, which represents the activating form
(Peshenko and Dizhoor, 2006). Increasing concentrations of free
Ca2+ diminish the activation process leading even to an inhi-
bition below the basal cyclase activity level (Duda et al., 1996).
This regulatory process of ROS-GC is essential for the photo-
responserecoveryofvisualcells (Mendezetal.,2001;Howesetal.,
2002).
Here, new observations on Ca2+-dependent modes of neuro-
calcin δ and GCAP1 in modulating membrane guanylate cyclase
signaling are presented. The results disclose a new model of
Ca2+-neurocalcin δ signaling of ANF-RGC and a new signal-
ing mechanism of GCAP1 in which it serves as an antithetical
Ca2+ sensor in the phototransduction and the olfactory sen-
sory neurons. Thus, they indicate an increasing complexity in
the regulatory modes of membrane guanylate cyclases and this
enables them to perform multiple cellular functions.
MATERIALS AND METHODS
Mutagenesis. Point mutations in ONE-GC and GCAP1 cDNA
wereintroducedusingQuickChangemutagenesiskit(Stratagene)
and appropriate mutagenic primers. ONE-GC F585Sm u t a t i o n -
Forwardprimer 5 -TGGCTGAAGAAGTCTGAGGCAGGCACG-
3 ; Reverse primer 5 -CGTGCCTGCCTCAGACTTCTTCAG
CCA-3  (the mutated sequence is underlined). Construction
of the GCAP1(D100E) mutant is described in detail in
(Kitiratschky et al., 2009). The mutants were veriﬁed by
sequencing. To construct the ANF-RGC Ext− mutant two
Hpa1 restriction sites were introduced at nucleotide posi-
tions 437–442 (Forward primer 5 -GTGGTGCTGCCGCTG
GTAAACAACACCTCGTACCCG-3 , Reverse primer 5 -CGG
GTACGAGGTGTTTACCAGCGGCAGCACCAC-3 ;H p a 1r e -
cognition sequence is underlined) and at nucleotide posi-
tions 1697–1702 (Forward primer 5 -AATGAGGACCCAG
CCGTAAACCAAGACCACTTT-3 ; Reverse primer 5 -AAAGTG
GTCTTGGTTTACGGCTGGGTCCTCATT-3 ; Hpa1 recognition
sequence is underlined). The 1242bp fragment was excised and
the remaining part was religated.
Expression in COS cells. COS7 cells (simian virus 40-
transformedAfricangreenmonkeykidneycells)weremaintained
in DMEM medium supplemented with 10% fetal bovine serum
and penicillin, streptomycin antibiotics on 10cm diameter cell
culture dishes in humidiﬁed atmosphere of 95% O2/5% CO2.
At approximately 65% conﬂuency the cells were transfected with
25μg of appropriate plasmid cDNA using calcium phosphate
co-precipitation technique (Sambrook et al., 1989). In control
experiments the cells were transfected with 25μgo fe m p t y
expression vector. 64h after transfection cells were washed with
50mM Tris-HCl pH 7.4/10mM Mg2+ buffer, homogenized and
the particulate fraction pelleted by centrifugation.
Guanylate cyclase activity assay. The membranes were incu-
bated on ice-bath with or without GCAP1 or neurocalcin δ
in the assay system containing 10mM theophylline, 15mM
phosphocreatine, 20μg creatine kinase and 50mM Tris-HCl,
pH 7.5.AppropriateCa2+ concentrations were adjusted with pre-
calibrated Ca2+/EGTA solutions (Molecular Probes). The total
assay volume was 25μl. The reaction was initiated by addition of
the substrate solution (4mM MgCl2 and 1mM GTP, ﬁnal con-
centration) and maintained by incubation at 37◦Cf o r1 0 m i n .
The reaction was terminated by the addition of 225μlo f5 0m M
sodium acetate buffer, pH 6.2 followed by heating on a boiling
water bath for 3min. The amount of cyclic GMP formed was
determined by radioimmunoassay(Nambi et al., 1982).
Expression and puriﬁcation of GCAP1, GCAP1(D100E) and
neurocalcin δ. GCAP1 was expressed and puriﬁed as in (Duda
et al., 1999), GCAP1(D100E) as in (Kitiratschky et al., 2009), and
neurocalcin δ as in (Duda et al., 2004).
Antibodies. The speciﬁcity of antibody against neurocalcin
δ has been described previously (Duda et al., 2004). Antibody
against ANF-RGC was raised against the kinase homology
domain in rabbits. Speciﬁcity of the antibody was tested through
Western blot using membranes of COS cells expressing all three
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receptor guanylate cyclases, ANF-RGC, CNP-receptor guanylate
cyclase (CNP-RGC) and enterotoxin receptor guanylate cyclase
(STa-RGC). The antibody recognized only ANF-RGC (data
not shown). The antibodies were afﬁnity puriﬁed. Secondary
antibodies conjugated to a ﬂuorescent dye (DyLight 488 and
DyLight 549) were purchased from Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA.
Immunohistochemistry. Mice were sacriﬁced by lethal injec-
tion of ketamine/xylazine (the protocol approved by the Salus
University IUCAC) and perfused through the heart, ﬁrst with a
standard Tris-buffered saline (TBS) and then with freshly pre-
pared 4% paraformaldehyde in TBS. The adrenal glands were
removed and ﬁxed for 1–4h in 4% paraformaldehyde with TBS
at 4◦C, cryoprotected in 30% sucrose overnight at 4◦Ca n dc u t
into 20μm sections using Hacker-Bright OTF5000 microtome
cryostat (HACKER Instruments and Industries Inc., Winnsboro,
SC). The sections were washed with TBS, blocked in 10% normal
s e r u mi nT B S / 0 . 5 %T r i t o nX - 1 0 0( T T B S )f o r1ha tr o o mt e m -
perature, washed with TTBS, incubated with respective antibody
in blocking solution overnight at 4◦C, washed with TTBS for and
then incubated with DyLight conjugated donkeyanti-rabbitanti-
body (200:1) for 1h, washed with TTBS. Images were acquired
using an inverted Olympus IX81 microscope/FV1000 Spectral
laser confocal system, and analyzed using Olympus FluoView
FV10-ASW software. Digital images were processed using Adobe
Photoshop software.
Western blot. After boiling in a gel-loading buffer
[62.5mM Tris-HCl, (pH 7.5), 2% SDS, 5% glycerol, 1mM
β-mercaptoethanol (βME), and 0.005% bromophenol blue] the
proteins (membranes of transfected COS cells or mouse adrenal
gland homogenate) were subjected to SDS-polyacrylamide gel
electrophoresis in a buffer (pH 8.3) containing 0.025M Tris,
0.192M glycine, and 0.1% SDS. The proteins were transferred
to immobilon membranes (Millipore) in the same buffer but
containing 5%methanol. The blotwasincubatedin (TBSpH7.5)
containing 100mM Tris-HCl, 0.9% NaCl, and 0.05% Tween-20
(TBS-T) with 5% powdered non-fat Carnation milk (blocking
buffer) overnight at 4◦C and rinsed with TBS-T. The antibodies
were added to the solution and the incubation continued for 1h
at room temperature. After the blot was rinsed with with TBS-T,
the incubation was continued with the secondary antibody con-
jugated to horseradish peroxidase in blocking buffer for another
h o u r .F i n a l l y ,t h eb l o tw a st r e a t e dw i t hS u p e r S i g n a l R West Pico
chemiluminescent substrate (Thermo Scienitifc; according to
the manufacturer’s protocol). The immunoreactive band was
visualized by exposing the blot to Kodak X-ray ﬁlm.
RESULTS AND DISCUSSION
ANF RECEPTOR GUANYLATE CYCLASE, ANF-RGC, IS MODULATED
BY Ca2+ SIGNALS
Neurocalcin δ transmits Ca2+ signal to ANF-RGC
Based on almost three decades of research the family of mam-
malian membrane guanylate cyclases has been ﬁrmly divided
into two subfamilies, receptor guanylate cyclases and intracellular
Ca2+ regulated guanylate cyclases. The ﬁrst group included the
receptor for natriuretic factor type A (ANF) and type B (BNP)
guanylate cyclase ANF-RGC, the receptor for type C natriuretic
peptide guanylate cyclase CNP-RGC, and heat-stable enterotoxin
(and also guanylin and uroguanylin) receptor guanylate cyclase
STa-RGC; the second group is comprised of the photoreceptor
guanylate cyclases ROS-GC1 and ROS-GC2 and the olfactory
neuroepithelium guanylate cyclase ONE-GC.
To determine whether a receptor guanylate cyclase could also
respond to Ca2+ signals transmitted to it through a calcium sen-
sor protein, the prototype receptor cyclase ANF-RGC and NCS
protein neurocalcin δ were chosen. A clue for selecting neurocal-
cin δ was the observation that it targets the conserved membrane
guanylate cyclase catalytic domain of ROS-GC1.
Membranes of COS cells expressing recombinant ANF-RGC
were incubated with series of increasing concentrations of puri-
ﬁed myristoylated neurocalcin δ at a ﬁxed 10μMC a 2+.N o
extracellular ligand of ANF-RGC, ANF or BNP, was added to
the reaction mixture. ANF-RGC activity was stimulated in the
neurocalcin δ concentration-dependent manner; half-maximal
activation of the cyclase occurred at ∼0.5μMa n dt h em a x i -
mal activation of 4.8-fold above the basal value was observed
at 2μM myristoylated neurocalcin δ (Figure1:c l o s e dc i r c l e s ) .
The calculated Hill’s coefﬁcient for the stimulatory effect was
2.1 ± 0.5. In the membranes of cells transfected with the vec-
tor alone the cyclase activity was negligible, 0.2pmol cyclic GMP
min−1(mg protein)−1 (Figure1:closeddiamonds)andwasunaf-
fected by neurocalcin δ i nt h ep r e s e n c eo fC a 2+.T ov e r i f yt h a t
the observed effect of Ca2+-neurocalcin δ is speciﬁc the cyclase
activity was measured in the presence of neurocalcin δ but in the
absence of Ca2+ (1mM EGTA was added to the reaction mix-
ture). The absence of Ca2+ did not affect the basal ANF-RGC
activity; it was 12 ± 2 pmol cyclic GMP min−1(mg protein)−1
FIGURE 1 | Ca2+-bound neurocalcin δ stimulates ANF-RGC activity.
COS cells were transfected with ANF-RGC cDNA and their membrane
fraction was analyzed for neurocalcin δ-dependent cyclase activity in the
absence (open circles) and presence of 10μMC a 2+ (closed circles). COS
cells transfected with an empty vector were analyzed identically (closed
diamonds). The extracellular hormone ligand of ANF-RGC, the atrial
natriuretic factor (ANF) was absent from the reaction mixture. The
experiment was done in triplicate and repeated four times. The results
shown are average ± SD from these experiments. The EC50 value was
determined graphically. Neurocalcin δ used was myristoylated. The
myristoylated form of neurocalcin δ was expressed and puriﬁed as
described in Krishnan et al. (2004).
Frontiers in Molecular Neuroscience www.frontiersin.org April 2012 | Volume 5 | Article 44 | 3Duda et al. Neurocalcin δ and GCAP1-modulated guanylate cyclase
in the presence of 10μMC a 2+ and 11.9 ± 1.8pmol cyclic GMP
min−1(mg protein)−1 i nt h ep r e s e n c eo f1 m ME G T A .I nt h e
absence of Ca2+ neurocalcin δ,h o w e v e r ,d i dn o ts t i m u l a t eA N F -
RGC activity (Figure1:o p e nc i r c l e s ) .T h u s ,A N F - R G Ca c t i v i t yi s
not only regulated by ANF or BNP; in vitro it is also regulated by
myristoylated neurocalcin δ i nt h ep r e s e n c eo fC a 2+.
Neurocalcin δ targets the intracellular domain of ANF-RGC
It is well established that ANF and BNP, the hormone-ligands
of ANF-RGC, signal through the cyclase’s extracellular domain
(Duda et al., 1991; Ogawa et al., 2004;r e v i e w e di nSharma,
2002, 2010). Neurocalcin δ, on the other hand, is an intracellu-
lar protein, therefore the respective target sites of these two types
of ligand, ANF/BNP and neurocalcin δ, reside on the opposite
sites of the transmembrane domain of ANF-RGC. To determine
the biochemical requirements for neurocalcin δ effect on ANF-
RGC activity namely, whether the isolated intracellular portion
of ANF-RGC is sufﬁcient for neurocalcin δ to exhibit its stimula-
tory effect or whether the intact ANF-RGC protein is necessary,
an ANF-RGC deletion mutant was prepared in which the extra-
cellular receptor domain (aa 12–433) was deleted. The mutant,
however, had retained the leader sequence to ensure its proper
membrane targeting. This mutant was transiently expressed in
COS cells and their membranes were appropriately treated with
ANF or myristoylated neurocalcin δ and 10μMC a 2+.B o t hp r o -
teins had comparable basal guanylate cyclase activities, 13 and
12.2 pmol cyclic GMP min−1(mg protein)−1 for the full-length
ANF-RGC and the deletion mutant, respectively. As expected, the
mutant was unresponsive to ANF (Figure2:o p e nc i r c l e s ) ,h o w -
ever, neurocalcin δ stimulated its activity in a dose-dependent
FIGURE 2 | The intracellular portion of ANF-RGC is sufﬁcient for
neurocalcin δ and Ca2+ to stimulate ANF-RGC activity. The ANF-RGC
deletion mutant lacking the extracellular receptor domain aa12–433, was
constructed and expressed in COS cells. The particulate fraction of these
cells was assayed for guanylate cyclase activity in the presence of
increasing concentrations of myristoylated neurocalcin δ and 10μMC a 2+ or
0.5mM ATP and increasing concentrations of ANF . Membranes of COS
cells expressing full-length ANF-RGC were processed in parallel as positive
control. The experiment was performed in triplicate and repeated two
times. The results shown are mean ± SD from these experiments.
fashion (Figure2: closed diamonds). The stimulatory proﬁle
was indistinguishable from that of the full-length ANF-RGC
(Figure2: closed circles). Also the Hill’s coefﬁcients for the neu-
rocalcin δ effect on both cyclases were identical 2.1 ± 0.5 and
2.05 ± 0.4 for the full-length ANF-RGC and for the deletion
mutant, respectively. It is, therefore, concluded that the extra-
cellular domain has no structural role in ANF-RGC ability to
respond to and be stimulated by myristoylated neurocalcin δ.
ANF-RGC and neurocalcin δ co-exist in the glomerulosa cells of the
adrenal gland
Are these in vitro biochemical ﬁndings on ANF-RGC activity
modulation by Ca2+ via neurocalcin δ of physiological rele-
vance? A ﬁrst hint could be the co-expression of both proteins
in the same tissue, organ or cell type. Guided by intuition the
mouse adrenal gland was analyzed for the presence of ANF-
RGC and neurocalcin δ, ﬁrst by Western blot and then through
immunocytochemistry.
The gland was homogenized and the homogenate after SDS-
polyacrylamide gel electrophoresis was analyzed for the presence
of ANF-RGC or neurocalcin δ by Western blot. As shown in
Figure3, with antibody against ANF-RGC as a probe (panel
“ANF-RGC”) an intense immunoreactive band was observed at
expected molecular weight of ∼130kDa. With neurocalcin δ
antibody as a probe (Figure3:p a n e l“ N C δ” )t h ep r e s e n c eo fa n
immunoreactive protein with mobility of ∼23kDa correspond-
ing to the molecular weight of neurocalcin δ was observed. These
results show that both ANF-RGC and neurocalcin δ areexpressed
in the mouse adrenal, they, however, do not provide information
whether these proteins are expressed in the same type of adrenal
gland cells. Todetermine whether these proteins co-localize in the
FIGURE 3 | ANF-RGC and neurocalcin δ are expressed in the mouse
adrenal gland. Mouse adrenal gland was homogenized in 50mM
Tri-HCl/10mM MgCl2 buffer (pH 7 .5) containing protease inhibitor cocktail
(Sigma). The proteins (∼40μg/lane) were subject to SDS-polyacrylamide
gel electrophoresis and analyzed by Western blot using antibody against
ANF-RGC or neurocalcin δ as described in the “Materials and Methods”
section. (A) immunoreactivity with ANF-RGC antibody.
(B) immunoreactivity with neurocalcin δ antibody.
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FIGURE 4 | ANF-RGC and neurocalcin δ are co-expressed in the
glomerulosa cells of mouse adrenal gland. (A) Serial cryosections of the
mouse adrenal gland were immunostained with neurocalcin δ (panel “NCδ”)
or ANF-RGC (panel “ANF-RGC”) antibodies. The DIC image showing the
integrity of the adrenal gland sections are presented at the left (“DIC”).
“Z.G.” and “Z.F-R.” denote zona glomerulosa and zona fasciculata-reticularis,
respectively. Intense staining with either antibody was observed
in the zona glomerulosa. (B) The immunostaining with the primary
antibodies is speciﬁc. The mouse adrenal gland cryosections were
processed identically as in (A) except that the primary antibody for ANF-RGC
or neurocalcin δ was omitted in the respective incubation mixture but
incubation with ﬂuorescently labeled secondary antibody was carried out as
in (A). The DIC image showing the integrity of the sections are presented
(“DIC”).
adrenal gland immunocytochemical analyzes were carried out.
Sections of the adrenal gland were immunostained with speciﬁc
antibodies against ANF-RGC and neurocalcin δ.B e c a u s eb o t h
antibodies used were raised in rabbits, co-immunostaining was
not feasible, therefore, staining of consecutive sections was per-
formed. The results are shown in Figure4A. Intense staining
with anti neurocalcin δ antibody was observed in the adrenal
zona glomerulosa (Figure4A:p a n e l“ N C δ” Z.G.). Also, strong
immunoreactivity with ANF-RGC antibodies was observed in
zona glomerulosa (Figure4A: panel “ANF-RGC” Z.G.). This
localization of ANF-RGC within the mouse adrenal gland is
consistent with the protein’s localization in the bovine adrenal
gland (Meloche et al., 1988). To verify the speciﬁcity of the
staining, in control reactions the primary antibodies were omit-
ted but secondary antibody was added. Without the primary
antibodies there was no speciﬁc staining in the sections ana-
lyzed (Figure4B: control). It was therefore concluded that both
ANF-RGC and neurocalcin δ co-exist in the adrenal glomeru-
losa cells. Although some faint staining in both sections was
observedfor the fasciculate-reticularis cells (Z.F-R. region in both
“NCδ” and “ANF-RGC” panels), without detailed co-localization
experiments it is not possible to conclude on ANF-RGC and
neurocalcin δ co-existence there.
The second question asked was: are ANF-RGC and neurocal-
cin δ co-existing in the adrenal gland functionally linked? Mouse
adrenal gland was homogenized in the presence of 1mM EGTA
or 10μMC a 2+, the particulate fraction was prepared and ana-
lyzed for guanylate cyclase activity. In the absence of Ca2+ the
activity was 70 ± 9 pmol cyclic GMP min−1 (mg protein)−1
and in the presence of Ca2+, 245 ± 28 pmol cyclic GMP
FIGURE 5 | Neurocalcin δ stimulates ANF-RGC in membranes of mouse
adrenal gland. Mouse adrenal gland was homogenized in Tris-Mg2+ buffer
pH 7 .4 with or without 10μMC a 2+. The particulate fractions were prepared
from each homogenate and assayed for guanylate cyclase activity. The
experiment was done in triplicate and repeated two times. The results
shown are average ± SD from these experiments.
min−1(mg protein)−1 (Figure5). At this stage it is not possible
to conclude with certainty, however, if native neurocalcin δ in
the adrenal gland is pre-bound to ANF-RGC or if it is under-
going a Ca2+ mirystoyl switch and interacts with ANF-RGC
in a reversible manner, the guanylate cyclase activity measured
at 10μMC a 2+ reﬂects the neurocalcin δ-stimulated ANF-RGC
activity.
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What is the physiological signiﬁcance of neurocalcin δ mod-
ulation of ANF-RGC activity in the adrenal zona glomerulosa?
At this moment there is no deﬁnite answer to this question. A
clue, however, may be provided by the facts that the adrenal
glomerulosa cells are the site of aldosterone synthesis, that aldos-
terone synthesis is triggered by the increase in cytosolic Ca2+
concentration, and that the ANF-RGC activity offsets the renin-
angiotensin-aldosterone system and inhibits aldosterone synthe-
sis (Burnett et al., 1984; Brenner et al., 1990; Aoki et al., 2000;
Shi et al., 2001). Because a measurable time is necessary for hor-
monal (ANF) turning “ON” the ANF-RGC signal transduction
system resulting in the inhibition of aldosterone synthesis, it is
tempting to hypothesize that before the hormonal ANF signal
is activated, Ca2+-bound neurocalcin δ stimulates ANF-RGC.
In this situation ANF-RGC response will be very rapid and the
cyclic GMP produced will start to inhibit aldosterone synthesis
almostimmediately. CyclicGMPsynthesized byANF-RGCaffects
number of effectors of aldosterone synthesis. They include cyclic
GMP-gatedchannels, cyclicGMP-dependentprotein kinases,and
cyclic GMP-regulated phosphodiesterases (reviewed in Lohmann
et al., 1997; Pfeifer et al., 1999). Several reports indicate that
cyclic GMP-driven inhibition of aldosterone synthesis is, at least
in part, mediated by cyclic GMP-stimulated phosphodiesterase
(PDE 2) that is expressed at high levels in adrenal glomerulosa
cells (MacFarland et al., 1991; Côté et al., 1999). This hypothesis
needs now experimental validation.
GCAP1 - ANTITHETICAL CALCIUM SENSOR
Since its discovery, GCAP1 has been exclusively regarded as the
component of the phototransduction machinery sensing the fall
in Ca2+ concentration after illumination, transmitting this infor-
mation to photoreceptor guanylate cyclase ROS-GC and stimu-
lating it to synthesize cyclic GMP at a faster rate (reviewed in
Pugh et al., 1997; Koch et al., 2010). With the ensuing raise
of Ca2+ concentration, Ca2+-bound GCAP1 inhibits ROS-GC
activity bringing it to the basal level. This activator/inhibitor
mode of GCAP1 operation is well established both in vivo and
in vitro.
Recent work, however, indicated that GCAP1 could target to
another sensory membrane guanylate cyclase, an odorant recep-
tor ONE-GC [alternatively termed GC-D (Fülle et al., 1995)]
expressed in a subpopulationof olfactory sensory neurons (Duda
et al., 2006; Pertzev et al., 2010).
GCAP1 transmits the Ca2+-stimulatory signal to the odorant
receptor guanylate cyclase, ONE-GC
Recombinant ONE-GC expressed in COS cell was exposed to
increasing Ca2+ concentrations and constant, 4μM, GCAP1
concentration. As a positive control, recombinant ROS-GC1
was treated identically. Both cyclases were expressed in COS to
approximatelythe same level asveriﬁed by Western blot(Figure6
inset). As expected, based on previous reports (Dudaet al., 1996),
at or below 10nM Ca2+, GCAP1 maximally stimulated ROS-
GC1 (Figure6: closed circles). The stimulation decreased with
increasing free Ca2+ concentration and the half-maximal inhibi-
tionwasatabout100nMCa2+.Contrarytothat,atabout100nM
Ca2+ there was practically no effect on GCAP1-dependent ONE-
GC activity (Figure6: open circles). However, with the Ca2+
FIGURE 6 | Antithetical Ca2+ modulated GCAP1 effect on ONE-GC and
ROS-GC1 activities. Membranes of COS cells expressing ONE-GC or
ROS-GC1 (control) were individually assayed for guanylate cyclase activity
in the presence of 4μM GCAP1 and indicated concentrations of Ca2+.T h e
experiment was carried out in triplicate and repeated three times. The
results shown are shown are average ± SD from these experiments. The
IC50 and EC50 values were determined graphically. Inset: Expression levels
of ROS-GC1 and ONE-GC in COS cells were monitored by Western blot
using antibodies against ROS-GC1 or ONE-GC.
concentrations increasing beyond 100nM there was a dose-
dependent increase in ONE-GC activity. The half-maximal acti-
vation of the cyclase occurred at 0.7μMC a 2+ and the maximal
activation atabout2.5μM.AtCa2+ concentrations above2.5μM
there wasnostatisticallysigniﬁcantincrease inthe cyclaseactivity.
The expression levels of ROS-GC1 and ONE-GCin COS cells was
comparable (Figure6: inset). These results essentially conﬁrm
the previous published in Duda et al. (2006). The main conclu-
sion is that GCAP1 can function as calcium-dependent regulator
of guanylate cyclase activity, but depending on the target it can
activate the cyclase in a Ca2+-dependent manner with reverse
premise making it an antithetical modulator.
How can GCAP1 exhibit these opposite modulatory effects?
To answer this question GCAP1 and ONE-GC mutants were
employed.
Several mutations in the GCAP1 gene have been found in
patients suffering from autosomal dominant cone-rod dystro-
phies (Behnen et al., 2010). All these mutations except one are
located within the regions coding for EF hands 3 and 4. The
D100E mutation is within EF hand 3; it causes perturbation in
Ca2+ coordination,andleadstoadramaticdecreaseinafﬁnityfor
Ca2+. As a consequence, the D100E mutant remains in an active
conformation at 10μMC a 2+. The activation is half-maximal at
20μMCa 2+ andthecyclaseactivity returns tothe basallevelonly
at approx. 60μMf r e eC a 2+ (Behnen et al., 2010; Dell’Orco et al.,
2010). This mutant was tested for its effect on ONE-GC activity
in the presence of two Ca2+ concentrations, 10nM and 10μM.
For comparison, in parallel experiment, the effect of the D100E
mutant on ROS-GC1 activity at the same Ca2+ concentrations
was determined. The results are shown in Figure7.T h em u t a n t
stimulated ROS-GC1 activity at both tested Ca2+ concentrations.
It, however, had no effect on ONE-GC activity at 10nM Ca2+
but stimulated its activity at 10μMC a 2+. Thus, dysfunctional EF
hand 3doesnothaveanyeffect onCa2+-dependentGCAP1 stim-
ulation of ONE-GC. Because the third EF hand has the highest
Frontiers in Molecular Neuroscience www.frontiersin.org April 2012 | Volume 5 | Article 44 | 6Duda et al. Neurocalcin δ and GCAP1-modulated guanylate cyclase
FIGURE 7 | The D100E GCAP1 mutant stimulates both ONE-GC and
ROS-GC1 at high Ca2+ concentration but only ROS-GC1 in the
absence of Ca2+. The membrane fraction of COS cells expressing ONE-GC
or ROS-GC1 (control) were assayed for guanylate cyclase activity in the
presence (2μM) or absence of D100E GCAP1 mutant and 1mM EGTA
(10μMC a 2+)o r1 0μMC a 2+. The experiment was done in triplicate and
repeated two times for reproducibility. The results shown are average ± SD
from these experiments.
afﬁnity for Ca2+ (Lim et al., 2009) these results indicated that
low afﬁnity Ca2+ binding to GCAP1 is sufﬁcient for ONE-GC
stimulation. These results further showed that the D100Em u t a -
tion in GCAP1 leads to a protein conformation that can act
as a constitutive activator with Ca2+-sensing properties that are
signiﬁcantly shifted to higher free Ca2+.O n ec a nd e d u c ef r o m
these results that the interaction sites of GCAP1 in ROS-GC1
and ONE-GC are different, i.e., are not located in correspond-
ing homologous regions. This hypothesis was tested by creating a
mutantof ONE-GC with a pointmutation in aregion thatis con-
served among sensory guanylate cyclases and that is critical for
GCAP1-dependent regulation of ROS-GC1.
GCAP1signaling modes in its Ca2+-free and Ca2+-bound states
are different
The ﬁrst ROS-GC1 gene mutation linked with visual disorder
was the F514S mutation identiﬁed in cases of Leber’s congenital
amaurosis type 1 (LCA1) (Perrault et al., 1996). Studies aimed
at explaining the molecular basis of LCA1 demonstrated that
this mutation totally disables GCAP1 modulation of ROS-GC1
activity (Duda et al., 1999). Because phenylalanine in this posi-
tion is conserved in all membrane guanylate cyclases, the obvious
question to ask was: would a similar mutation in ONE-GC dis-
able GCAP1-mediated Ca2+ signaling of its activity? ONE-GC
F585Sm u t a n t( c o r r e s p o n d i n gt ot h eF 514Si nR O S - G C 1 )w a sc o n -
structed and its activity was determined in the presence of 10μM
Ca2+ andincreasingconcentrations ofGCAP1(Figure8A:c l o s e d
circles). The results show that contrary to ROS-GC1 and its F514S
mutant (Figure8A: open and closed triangles, respectively; the
activity wasmeasuredintheabsenceofCa2+),the F→Smutation
in ONE-GC does not affect the Ca2+-GCAP1-dependent activa-
tion of the cyclase (Figure8A: compare the proﬁles with closed
andopen circles).The Hill’s coefﬁcients calculatedforthe GCAP1
stimulation of wt ONE-GC and of its F585S mutant were virtually
identical, 1.83 ± 0.3. The mutation also does not affect the Ca2+
sensitivity of the mutant (Figure8B:c o m p a r et h ec l o s e da n d
FIGURE 8 | F585S mutation does not affect Ca2+-GCAP1 signaling of
ONE-GC activity. (A) Membranes of COS cells expressing ONE-GC or its
F585S mutant were assayed for guanylate cyclase activity in the presence
of increasing concentrations of GCAP1 and constant 10μMC a 2+;
Membranes of COS cells expressing ROS-GC1 or its F514S mutant were
analyzed for GCAP1 effect in the absence of Ca2+ (1mM EGTA was
present in the assay mixture). (B) Membranes of COS cells expressing
ONE-GC and its F585S mutant or ROS-GC1 and its F514S mutant were
analyzed by Western blot using antibodies against ROS-GC1 and ONE-GC.
Approx 20μg of membrane protein was applied on each lane of the gel.
Lane 1, ONE-GC; Lane 2, ONE-GC F585S; Lane 3, ROS-GC1; Lane 4,
ROS-GC1 F514S. (C) Membranes of COS cells expressing ONE-GC or its
F585S mutant were assayed for guanylate cyclase activity in the presence
of increasing concentrations of Ca2+ and constant, 4μM GCAP1. The
experiments were done in triplicate and repeated for reproducibility with
different preparations of transfected COS cells. The results presented
(mean ± SD) are from one representative experiment.
open circles). It is, therefore, concludedthat Ca2+-free and Ca2+-
bound GCAP1 exert different signals for activation of membrane
guanylate cyclase. They probably do so by acting on different
target regions, since the mutation F514Si sl o c a t e di nap r e v i -
ouslyidentiﬁed interaction and/orregulatoryregion ofROS-GC1
(Lange et al., 1999). Finally, while the F514Sm u t a t i o ni nR O S -
GC1resultsinblindnessatbirthorsoonthereafter (Perraultetal.,
1996), the corresponding F585Sm u t a t i o ni nO N E - G Cw o u l dn o t
result in anosmia.
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